Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing on the CSE

Published: September 15, 2023

Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing on the CSE

Safe Supply Streaming Co. Ltd. and Origin Therapeutics Holdings Inc. announced that they have received conditional approval to list Safe Supply’s common shares on the Canadian Securities Exchange (CSE). Final approval and trading of the Company shares are subject to fulfilling customary CSE requirements. Safe Supply and Origin anticipate that trading will commence within the month of September 2023 for which shareholders and stakeholders will receive due notice.

Additionally, Origin recently announced that it received shareholder approval for the proposed transaction with Safe Supply and will move forward with the planned share consolidation.Upon trading, the Company will have fulfilled its transactional requirements detailed in the definitive agreement pertaining to the release of funds escrowed (See Press Release dated August 1, 2023) totalling $2,386,000 through

At the time of trading, the resulting issuer will change its name to “Safe Supply Streaming Co Ltd” under a trading symbol to “SPLY” and will begin to fund investments in the burgeoning safe supply ecosystem.

About Safe Supply
Safe Supply is the world’s first company investing in the legal and regulated supply of drugs that traditionally have been accessible only through the illicit drug market. Led by the pioneers behind the cannabis and psychedelics industries, Safe Supply is actively deploying capital in the third wave of drug reform, specifically on ending the fentanyl crisis and emerging opportunities for the coca plant. The company’s focus is investing and incubating companies across the ecosystem to address the physical, financial and emotional damage from drug abuse with promising products, solutions and technologies across the entire safe supply value chain.